retatrutide clinical trials saudi arabia SFDA Approves Clinical Trial for a Gene Therapy Developed in Saudi Arabia to Treat Acute Lymphoblastic Leukemia Retatrutide ("Reta") Is Trending on
Pay in 4 interest-free payments of $5.03 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
























